COMMUNIQUÉS West-GlobeNewswire

Oxford Biomedica Interim Results
04/09/2019
OXFORD BIOMEDICA PLC INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2019 Oxford, UK – 4 September 2019: Oxford Biomedica plc (“Oxford Biomedica” or “the Group”) (LSE: OXB), a leading gene and cell therapy group, today [...]
Cyclacel Pharmaceuticals to Present at the 21st Annual H.C. Wainwright Global Investment Conference
04/09/2019
BERKELEY HEIGHTS, N.J., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on [...]
Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2019
04/09/2019
CRANBURY, N.J., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced upcoming presentations at the following investor conferences in September. Bradley Campbell, President and Chief [...]
Idera Pharmaceuticals Announces Immuno-Oncology Clinical Research Collaboration with AbbVie
04/09/2019
EXTON, Pa., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) announced today that they have entered into an immuno-oncology clinical research collaboration with AbbVie, a global, research- [...]
Prevail Therapeutics to Present at Morgan Stanley 2019 Global Healthcare Conference
04/09/2019
NEW YORK, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Prevail Therapeutics Inc. (Nasdaq: PRVL) (“Prevail” or “the Company”), a biotechnology company developing potentially disease-modifying AAV-based gene therapies for patients [...]
Tonix Pharmaceuticals Doses Participants in Phase 1 Study Evaluating TNX-601 for the Daytime Treatment of Posttraumatic Stress Disorder
04/09/2019
NEW YORK, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that participants were dosed in a Phase [...]
BioCryst Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
04/09/2019
RESEARCH TRIANGLE PARK, N.C., Sept. 04, 2019 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted five newly-hired [...]
Oncology Venture appoints new CEO and CFO and proposes rights issue to facilitate a focused commercial strategy
04/09/2019
Press release Hoersholm, Denmark, September 4, 2019 – Oncology Venture A/S (Nasdaq First North Growth Market Stockholm: OV.ST) today announces the appointments of a new CEO and a new CFO, and its plan to propose a [...]
XORTX Highlights New Research on Polycystic Kidney Disease Awareness Day
04/09/2019
● New Study Shows a Novel Form of Injury Linking Uric Acid Crystals in Urine and ADPKD Progression ● CALGARY, Alberta, Sept. 04, 2019 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE: XRX [...]
Oxurion Completes Enrolment of Phase 1 Clinical Trial Evaluating THR-687, a Novel Pan-RGD Integrin Antagonist, for the Treatment of Diabetic Macular Edema (DME)
04/09/2019
Company on Track for Data Read Out by End of 2019 Leuven, Belgium, 4 September 2019 – 7.30 AM CET – Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing innovative treatments to preserve vision [...]
Roche to present pivotal data for satralizumab in neuromyelitis optica spectrum disorder and six-year OCREVUS data in multiple sclerosis at ECTRIMS
04/09/2019
Investigational medicine satralizumab significantly reduces the risk of relapse in pivotal SAkuraStar monotherapy study for neuromyelitis optica spectrum disorder New data provide insights into neurofilament light chain [...]
Correction: Medtronic EVP & CFO Karen L. Parkhill to Speak at Morgan Stanley Global Healthcare Conference
04/09/2019
The press release published today at 11:00 a.m. EDT contained the incorrect presentation time. The correct version is below. DUBLIN, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in [...]
President & CEO of Nova Leap Health Corp. to Present at Richmond Club Event
04/09/2019
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Sept. 03, 2019 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a 2019 [...]
MediPharm Labs Enters into Agreements with Australian Licensed Producer & Forms Multiple Cannabis Supply Partnerships to Advance Australian Market Leadership
04/09/2019
Construction of New Melbourne-area Extraction Facility on Schedule Further Strengthens Australian Leadership Team Awarded Australian Cannabis Industry 2019 Innovation Award BARRIE, Ontario, Sept. 04, 2019 (GLOBE [...]
PRA Health Sciences, Inc. Announces $500 Million Share Repurchase Program
03/09/2019
RALEIGH, N.C., Sept. 03, 2019 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (the “Company”) (NASDAQ: PRAH) today announced that its Board of Directors (the “Board”) has authorized a $500 million share repurchase program [...]
PRA Health Sciences, Inc. Announces Secondary Offering and Concurrent Share Repurchase
03/09/2019
RALEIGH, N.C., Sept. 03, 2019 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (the “Company”) (NASDAQ: PRAH) today announced that KKR PRA Investors L.P. (the “Selling Stockholder”), intends to offer for sale in an [...]
Natus to Present at 2019 Wells Fargo Healthcare Conference
03/09/2019
PLEASANTON, Calif., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of [...]
Beyond Air™ to Present at the 21st Annual H.C. Wainwright Global Investment Conference
03/09/2019
GARDEN CITY, N.Y. and REHOVOT, Israel, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) [...]
Hepion Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements
03/09/2019
EDISON, N.J., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a biopharmaceutical company focused on the development of therapeutic drugs for the treatment of liver disease arising from [...]

Pages